These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 1281024

  • 1. Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Wilton P.
    Acta Paediatr Suppl; 1992 Sep; 383():137-42. PubMed ID: 1281024
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factors and their binding proteins in patients with growth hormone receptor deficiency: suggestions for new diagnostic criteria. The Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Blum WF, Ranke MB, Savage MO, Hall K.
    Acta Paediatr Suppl; 1992 Sep; 383():125-6. PubMed ID: 1281023
    [No Abstract] [Full Text] [Related]

  • 3. Effects of recombinant insulin-like growth factor I on IGF binding proteins and the acid-labile subunit in growth hormone insensitivity syndrome.
    Walker JL, Baxter RC, Young S, Pucilowska J, Clemmons DR, Underwood LE.
    Growth Regul; 1993 Mar; 3(1):109-12. PubMed ID: 7683514
    [No Abstract] [Full Text] [Related]

  • 4. The little women of Loja--growth hormone-receptor deficiency in an inbred population of southern Ecuador.
    Rosenbloom AL, Guevara Aguirre J, Rosenfeld RG, Fielder PJ.
    N Engl J Med; 1990 Nov 15; 323(20):1367-74. PubMed ID: 2233903
    [Abstract] [Full Text] [Related]

  • 5. Laron syndrome due to a post-receptor defect: response to IGF-I treatment.
    Laron Z, Klinger B, Eshet R, Kaneti H, Karasik A, Silbergeld A.
    Isr J Med Sci; 1993 Dec 15; 29(12):757-63. PubMed ID: 8300382
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS.
    Clin Nephrol; 1999 Aug 15; 52(2):103-9. PubMed ID: 10480221
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone insensitivity syndromes: a preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I. Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Blum WF, Hall K, Ranke MB, Wilton P.
    Acta Paediatr Suppl; 1993 Sep 15; 82 Suppl 391():15-9. PubMed ID: 7693071
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M, Cabrol S, Perin L, Ducos B, Bensman A, Le Bouc Y.
    Growth Horm IGF Res; 2000 Dec 15; 10(6):332-41. PubMed ID: 11161964
    [Abstract] [Full Text] [Related]

  • 9. Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism).
    Walker JL, Ginalska-Malinowska M, Romer TE, Pucilowska JB, Underwood LE.
    N Engl J Med; 1991 May 23; 324(21):1483-8. PubMed ID: 2023608
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-I.
    Laron Z, Klinger B, Blum WF, Silbergeld A, Ranke MB.
    Clin Endocrinol (Oxf); 1992 Mar 23; 36(3):301-4. PubMed ID: 1373347
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome.
    Klinger B, Jensen LT, Silbergeld A, Laron Z.
    Clin Endocrinol (Oxf); 1996 Oct 23; 45(4):423-9. PubMed ID: 8959080
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone and insulin-like growth factor regulate insulin-like growth factor-binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature.
    Laron Z, Suikkari AM, Klinger B, Silbergeld A, Pertzelan A, Seppälä M, Koivisto VA.
    Acta Endocrinol (Copenh); 1992 Oct 23; 127(4):351-8. PubMed ID: 1280392
    [Abstract] [Full Text] [Related]

  • 17. Clinical spectrum of the syndrome of growth hormone insensitivity. Advisory Committee on Growth Hormone Insensitivity.
    Savage MO, Chatelain PG, Preece MA, Ranke MB, Sietnieks A, Wilton P.
    Acta Paediatr Scand Suppl; 1991 Oct 23; 377():87-90; discussion 91. PubMed ID: 1723836
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of exogenous insulin-like growth factor I on insulin-like growth factor binding proteins in a case of growth hormone insensitivity (Laron-type).
    Gourmelen M, Perin L, Binoux M.
    Acta Paediatr Scand Suppl; 1991 Oct 23; 377():115-7. PubMed ID: 1723834
    [Abstract] [Full Text] [Related]

  • 20. Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism.
    Laron Z, Klinger B, Jensen LT, Erster B.
    Clin Endocrinol (Oxf); 1991 Aug 23; 35(2):145-50. PubMed ID: 1934530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.